Difficulty: Medium
Average Score: 77%
Practice
This drug inhibits the angiotensin-converting enzyme:
Correct answer
D
Rationale
In the context of pharmacology, understanding the mechanisms of action of cardiovascular drugs is essential for healthcare professionals. In this question, the correct answer is D) All of the above. These drugs, captopril, enalapril, and ramipril, belong to the class of medications known as ACE inhibitors.
ACE inhibitors work by blocking the angiotensin-converting enzyme, which is responsible for converting angiotensin I into angiotensin II. By inhibiting this enzyme, ACE inhibitors reduce the production of angiotensin II, a potent vasoconstrictor, leading to vasodilation, decreased blood pressure, and reduced workload on the heart.
Choice A, Captopril, was the first ACE inhibitor developed and is commonly used in clinical practice. Enalapril (choice B) and Ramipril (choice C) are also ACE inhibitors with similar mechanisms of action but differ in factors like duration of action and dosing frequency.
Understanding the subtle differences between these drugs is crucial for healthcare professionals to make informed decisions when prescribing medications for cardiovascular conditions. It is important to note that while all three options inhibit the angiotensin-converting enzyme, each drug may have specific indications, contraindications, and side effect profiles that healthcare providers need to consider when managing patients with cardiovascular diseases.
ACE inhibitors work by blocking the angiotensin-converting enzyme, which is responsible for converting angiotensin I into angiotensin II. By inhibiting this enzyme, ACE inhibitors reduce the production of angiotensin II, a potent vasoconstrictor, leading to vasodilation, decreased blood pressure, and reduced workload on the heart.
Choice A, Captopril, was the first ACE inhibitor developed and is commonly used in clinical practice. Enalapril (choice B) and Ramipril (choice C) are also ACE inhibitors with similar mechanisms of action but differ in factors like duration of action and dosing frequency.
Understanding the subtle differences between these drugs is crucial for healthcare professionals to make informed decisions when prescribing medications for cardiovascular conditions. It is important to note that while all three options inhibit the angiotensin-converting enzyme, each drug may have specific indications, contraindications, and side effect profiles that healthcare providers need to consider when managing patients with cardiovascular diseases.